biopharma-reporter17h
Neogap Therapeutics move into clinic with personalized cancer immunotherapy
The Swedish biotech hopes its precision therapy will help patients with advanced solid tumors who currently have few ...
biopharma-reporter23h
Nanobiotix’s radiotherapy-activated nanoparticle cancer candidate enters Phase 2
The French biotech company Nanobiotix announced today that it has dosed the first patient in the CONVERGE study, a Phase 2 ...